Lanean...
Cytotoxicity and Pharmacokinetics of Four Platinum Salts in Human Colon Carcinoma Cell-Line HCT116
BACKGROUND: Adding oxaliplatin to 5-FU–based regimens improves outcomes of patients with colorectal cancer in the metastatic and adjuvant settings. The benefit of adding oxaliplatin (or other radiosensitizers) to chemoradiotherapy for rectal cancer has been suggested, but the best oxaliplatin schedu...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
International Society of Gastrointestinal Oncology
2010
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056300/ |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|